We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent ...

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

The firm adds that robust sales of GLP-1 weight-loss products, along with higher sales of specialty and oncology drugs, are driving Cencora’s strong performance, and Argus is boosting its FY25 ...

Cencora, Inc. is a pharmaceutical sourcing ... over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers.

Cencora reported first-quarter fiscal 2025 ... including increased sales of GLP-1 drugs and specialty products. Segmental operating income totaled $767.3 million, up 9.9% year over year.